As of 2025-09-14, the Relative Valuation of TherapeuticsMD Inc (TXMD) is (0.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.11 USD, the upside of TherapeuticsMD Inc based on Relative Valuation is -141.4%.
The range of the Relative Valuation is (0.54) - (0.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 7.5x | 7.2x |
| Forward P/E multiples | 13.7x - 18.3x | 16.0x |
| Fair Price | (0.54) - (0.30) | (0.46) |
| Upside | -148.8% - -127.0% | -141.4% |
| Date | P/E |
| 2025-09-11 | -27.98 |
| 2025-09-10 | -27.73 |
| 2025-09-09 | -27.22 |
| 2025-09-08 | -27.22 |
| 2025-09-05 | -27.22 |
| 2025-09-04 | -27.22 |
| 2025-09-03 | -27.85 |
| 2025-09-02 | -26.72 |
| 2025-08-29 | -27.98 |
| 2025-08-28 | -28.23 |
| 2025-08-27 | -28.23 |
| 2025-08-26 | -28.26 |
| 2025-08-25 | -27.98 |
| 2025-08-22 | -27.73 |
| 2025-08-21 | -27.22 |
| 2025-08-20 | -27.98 |
| 2025-08-19 | -29.24 |
| 2025-08-18 | -28.74 |
| 2025-08-15 | -29.49 |
| 2025-08-14 | -28.99 |
| 2025-08-13 | -29.24 |
| 2025-08-12 | -27.85 |
| 2025-08-11 | -27.22 |
| 2025-08-08 | -26.75 |
| 2025-08-07 | -27.73 |
| 2025-08-06 | -27.85 |
| 2025-08-05 | -27.73 |
| 2025-08-04 | -27.73 |
| 2025-08-01 | -27.98 |
| 2025-07-31 | -28.23 |
| 2025-07-30 | -28.48 |
| 2025-07-29 | -29.24 |
| 2025-07-28 | -29.49 |
| 2025-07-25 | -30.00 |
| 2025-07-24 | -28.74 |
| 2025-07-23 | -30.25 |
| 2025-07-22 | -28.74 |
| 2025-07-21 | -29.24 |
| 2025-07-18 | -28.99 |
| 2025-07-17 | -28.99 |
| 2025-07-16 | -28.99 |
| 2025-07-15 | -28.61 |
| 2025-07-14 | -29.49 |
| 2025-07-11 | -29.74 |
| 2025-07-10 | -30.25 |
| 2025-07-09 | -30.75 |
| 2025-07-08 | -29.74 |
| 2025-07-07 | -29.49 |
| 2025-07-03 | -29.74 |
| 2025-07-02 | -28.74 |